Community tobacco control leaders' perceptions of harm reduction

被引:26
作者
Joseph, AM
Hennrikus, D
Thoele, MJ
Krueger, R
Hatsukami, D
机构
[1] Univ Minnesota, Transdisciplinary Tobacco Use Res Ctr, Ctr Canc, Minneapolis, MN USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Extens Serv, St Paul, MN 55108 USA
[4] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[5] Vet Adm Med Ctr, Sect Gen Internal Med 1110, Minneapolis, MN 55417 USA
关键词
D O I
10.1136/tc.2003.004242
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: To investigate community tobacco control leaders' attitudes toward harm reduction approaches to tobacco use, in order to assess benefits and risks associated with these strategies. Design: Cross sectional design involving qualitative outcomes from nine structured focus groups. Subjects: 47 community tobacco control leaders in Minnesota working in the areas of public policy, clinical treatment of nicotine dependence and youth development participated. Outcome measures: Participants discussed definitions of harm reduction; benefits and risks of harm reduction methods; and how funds for tobacco control research and programmes should be allocated. Results: Results indicated inconsistency about the definition of harm reduction: most groups included a broad range of strategies that extended beyond those typically referenced in the scientific literature. Many participants stated that harm reduction might be beneficial, particularly for smokers who could not or would not quit. However, most also expressed concern about a number of risks, including delivering a mixed message about tobacco, inadvertently benefiting the tobacco industry, and causing unanticipated negative health effects. Participants were inclined to suggest public policy measures (for example, smoking bans, increased taxes) as means for reducing harm. Conclusions: Results indicate that even among tobacco control leaders there is a need for common terminology to describe harm reduction approaches and that public policy approaches to harm reduction are considered more dependable than strategies that involve pharmaceutical treatment or rely on the tobacco industry, such as product modification.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 16 条
[1]  
[Anonymous], 2001, TOB CONTR MON
[2]   LONG-TERM FOLLOW-UP (3-4 YEARS) OF TREATMENT FOR SMOKING REDUCTION [J].
COLLETTI, G ;
SUPNICK, JA ;
RIZZO, AA .
ADDICTIVE BEHAVIORS, 1982, 7 (04) :429-433
[3]   Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial [J].
Etter, JF ;
Laszlo, E ;
Zellweger, JP ;
Perrot, C ;
Perneger, TV .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) :487-495
[4]  
Fagerstrom K O, 1997, Tob Control, V6, P311
[5]  
Fiore MC., 2000, TREATING TOBACCO USE
[6]   LONG-TERM EFFECTS OF A CONTROLLED SMOKING PROGRAM - A 2 1/2 YEAR FOLLOW-UP [J].
GLASGOW, RE ;
KLESGES, RC ;
KLESGES, LM ;
VASEY, MW ;
GUNNARSON, DF .
BEHAVIOR THERAPY, 1985, 16 (03) :303-307
[7]  
HATSUKAMI DK, 2002, NICOTINE TOB RES, pS89
[8]  
Hughes JR, 2000, ADDICTION, V95, pS3
[9]  
Hurt R D, 2000, Nicotine Tob Res, V2, P327, DOI 10.1080/713688154
[10]   Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction [J].
Kozlowski, LT ;
Strasser, AA ;
Giovino, GA ;
Erickson, PA ;
Terza, JV .
TOBACCO CONTROL, 2001, 10 (03) :201-203